unknown
Stage
About
GenomeDx Biosciences Inc develops genomic-based diagnostic tests to improve the accuracy of prostate and other cancer diagnoses and treatment decisions.
Explore GenomeDx Biosciences Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.